For immunocompetent children aged 11-12, the HPV vaccine is recommended as which dosing schedule?

For immunocompetent children aged 11-12, the HPV vaccine is recommended as which dosing schedule?

• A. Three-dose series between 11-12 years.
• B. One-dose series.
• C. Two-dose series between 15-16 years.
• D. Two-dose series between 11-12 years with at least 6 months between doses.

Answer: (D)

Starting HPV vaccination before age 15 uses a two-dose schedule because the immune system responds strongly enough with two doses when initiation occurs in younger adolescents. The second dose should be given at least six months after the first to ensure a robust and lasting antibody response, which provides effective protection while avoiding the need for a third dose in this age group. This is why the recommended plan for immunocompetent children who are 11–12 years old is a two-dose series with at least a six-month interval between doses. If vaccination is started at age 15 or older, a three-dose series is required instead, and the option of a one-dose schedule does not provide proven protection.

Starting HPV vaccination before age 15 uses a two-dose schedule because the immune system responds strongly enough with two doses when initiation occurs in younger adolescents. The second dose should be given at least six months after the first to ensure a robust and lasting antibody response, which provides effective protection while avoiding the need for a third dose in this age group.

This is why the recommended plan for immunocompetent children who are 11–12 years old is a two-dose series with at least a six-month interval between doses. If vaccination is started at age 15 or older, a three-dose series is required instead, and the option of a one-dose schedule does not provide proven protection.